Orthopedic Implants Market To Reach $6.2 Billion By 2024

The global orthopedic implants market is expected to reach USD 6.2 billion by 2024, according to a new report by Grand View Research, Inc. Major drivers, such as the surging geriatric population count and the increasing number of sports injuries are fueling the demand for the orthopedic prostheses globally.

The soaring number of road accidents and sports injuries is continually engendering the multitude of worldwide trauma cases. In addition, people above the age of 65 years are highly prone to orthopedic diseases and fractures since bone density progressively reduces with increasing age. Thus, the growth in the number of trauma cases and the escalating elderly population is further driving the target patient base for prosthetic implants.

On the other hand, the cost prohibitive nature of these implants coupled with the inadequate reimbursement coverage is the prime factor restraining the growth of the global market. In addition, the existent stringent regulatory framework and the frequent product recalls are some of the other factors further challenging the growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/orthopedic-implants-market

Further key findings from the study suggest:

The knee replacement segment captured the largest share of the global market in 2015, which is attributable mainly tothe high prevalence of osteoporosis and arthritis.
The orthopedic implants for long bones are anticipated to show the fastest growth rate owing to the constantly rising sports injuries and accident trauma cases.
North America captured the largest market share of 53.4% in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a well-defined regulatory framework, recommendations of government and healthcare agencies, and the current high adoption rate of minimally invasive procedures are the major factors supporting the growth of the market in North America.
Asia Pacific is anticipated to exhibit fast paced growth during the forecast period due mainly to therising disposable income, growing awareness with regard to improved and advanced orthopedic prostheses, progressively improving healthcare infrastructure, and the flourishing medical tourism industry are some of the factors rendering the Asia Pacific region attractive to the international players.
The global orthopedic implants market is fragmented with the presence of many local players. Thus, market players are adopting strategies including mergers and acquisitions and distribution partnerships to expand their overall market share and sustain themselves in the competition.
Some key players operating in this market include Zimmer Biomet Holdings, Inc., Stryker Corporation, DepuySynthes, Smith & Nephew plc, Wright Medical Group N.V, and Medtronic Plc.

Latin America In Vitro Diagnostics Market Size To Reach $5.1 Billion By 2024

The latin america IVD market is expected to reach over USD 5.1 billion by 2024, according to a new report by Grand View Research, Inc. The Latin America IVD market is expected to grow at a significant CAGR till 2024 owing to the rising prevalence of target disorders, aging population, and the presence of favorable government initiatives for early disease diagnosis. Other factors that are anticipated to boost the growth include the introduction of technologically advanced instruments and the increasing R&D initiatives for the development of disease-specific kits.

Regular testing for diabetes, cardiovascular, cancer, and sexually transmitted diseases are necessary for the timely treatments, further avoiding the risk of fatal health complications. The availability of tests for home and near patient testing is estimated to further enhance the usage rates of these devices. From November 2015, the Anvisa, which is a regulatory body for medical devices in Brazil, has started allowing the registration for HIV self-testing kits.

The increasing adoption point of care devices coupled with the increasing awareness among the healthcare professionals regarding the early diagnosis of various diseases has provided a boost to the Latin IVD market. The rising epidemic of communicable diseases in the southernpart of Latin America, the growing need for rapid and accurate diagnostics, and the changing healthcare infrastructure scenario are some of the key drivers of the Latin IVD market.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/latin-america-in-vitro-diagnostics-ivd-market

Further key findings from the study suggest:

The instrument segment is one of the most important segments of in vitro diagnostics. The presence of highly automated analyzers and the availability of over the counter products are some of the factors responsible for its significant share.
The Molecular diagnostics segment is anticipated to be the fastest growing technology over the decade. Molecular diagnostics is a transformative area of diagnostics. The continuous innovation in technology helps the physicians for critical decision making
The infectious disease segment held the largest share in 2015 over 24% owing to the presence of favorable government initiatives in association with the WHO to curb communicable diseases.
The home care segment is estimated to witness a significant growth over the forecast period. The high number of R&D initiatives undertaken by key competitors for the development of portable IVD devices with improved sensitivity and user-friendliness is a key factor attributing towards its growth.
In 2015, Brazil was the largest regional segment with a revenue generation of over USD 1.2 billion owing to the established healthcare infrastructure, growing awareness for cancer screening, and the increasing demand for genetic testing.
Peru is expected to be one of the fastest growing regions on account of the growing economic stability, high unmet clinical needs, and the rising disposable incomes
Key players operating in the Latin America IVD market are Roche Diagnostics, Abbott Laboratories, Inc., Hologic (Gen-Probe), Becton Dickinson (BD) Company, Alere, Inc., Bio-Rad Laboratories, Qiagen N.V., Inc., bioMerieux, BioQuidel Corporation, and Siemens Healthcare.

Skid Steer Loaders Market Worth $2.6 Billion By 2025

The global skid steer loaders market size is expected to reach USD 2.6 billion by 2025, exhibiting a revenue based CAGR of 2.4% over the forecast period, according to a study conducted by Grand View Research, Inc. Regulated demand from the construction sector coupled with introduction of several state-of-the-art skid steer loader variants with superior features such as compact size, and easy operability, are the major factors driving the demand. In addition, the rising adoption of skid loaders for landscaping activities is also expected to have a positive impact on the product demand.

Another major reason contributing to the demand for skid steer loaders is their ability to get into tight spaces. Although the machines are small in size, they have enough power to perform heavy construction activities. For instance, the Bobcat S70 has a width of only 901 mm but is equipped with a 23.5 horsepower engine and has a rated operating capacity of 343 kg.

The growing preference for comfort among operators is compelling manufacturers to focus on manufacturing loaders with enhanced cabin comfort. For instance, CNH Industrial N.V. offers skidsteers with a cabin that have increased headroom and improved visibility. Similarly, recently introduced AB Volvo’s C-Series skid steer loaders offer operators with 27% more cabin space as compared to their previous models. Thus, growing preference for improved comfort and operational efficiency is expected to drive growth of the skid steer loaders market over the forecast period.

Skid loaders have numerous advantages over other construction equipment that make it popular in the construction industry. The machines can perform different tasks and can operate on different types of terrains. The wheeled models can be used on uneven or rough terrains by installing Over-The-Tire (OTT) tracks that are easy to maintain and replace. The abovementioned benefits, coupled with lower operating costs, are anticipated to surge demand for skidsteers over the next six years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/skid-steer-loaders-market

Further key findings from the report suggest:

Skidsteers with Rated Operating Capacity (ROC) between 1,251 lbs to 2,200 lbs accounted for the highest market share in 2018 as these products offer optimal balance of power and initial cost
The more than 2,200 lbs segment is anticipated to expand at a significant CAGR over the forecast period, owing to the additional comfort and operational efficiency offered
The agricultural segment is gaining traction due to the flexibility offered by skid loaders, thereby eliminating the need for multiple machines across different operations
Construction and mining segment accounted for more than 50% of value share in 2018. Skidsteers were primarily introduced for construction activities and hence are widely used across the construction facilities
Middle East and Africa skid steer loaders market is primarily driven by rising infrastructure projects in the region

Distributed Acoustic Sensing Market Size Worth $775.8 Million By 2025

The global distributed acoustic sensing market size is expected to reach USD 775.8 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to exhibit a CAGR of 11.5% from 2019 to 2025. The use of fiber optic sensors is progressively increasing in the oil and gas industry since they provide a data-rich perspective on micro-seismicity and fracturing process. Also, with the increasing importance of border surveillance, distributed acoustic sensing systems are being highly used in the security and surveillance industry since they provide high-reliability and low-cost surface crossing and tunnel construction detection. Due to the high potential of intrusion detection, the adoption of DAS systems is growing in several asset protection-related applications, such as railways, high-value facility perimeters, and oil and gas pipelines.

The economic benefits of distributed acoustic sensing are anticipated to create growth opportunities for the market in the forthcoming years. The key drivers include the prevention of construction damages and pipeline thefts. DAS systems can perform the early detection of leakages, corrosion, erosion, and malicious third-party intrusion, which offer economic benefits to the industry. Also, they provide real-time monitoring of assets and perimeters, which provides improved security. Therefore, distributed acoustic sensors are used in various end-user industries for long-distance tracking of the acoustic signals generated by external interferences.

The Asia Pacific distributed acoustic sensing market is expected to witness substantial growth over the forecast period, owing to the emerging trends, such as increasing penetration of seismology. According to the U.S. Energy Information Administration, the region accounted for approximately 10% of the world’s crude oil production in 2018. China alone contributed approximately 5% of global crude oil production in the same year. Due to the presence of substantial oil and gas industries, the region is expected to demonstrate significant growth in distributed acoustic sensing shortly.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/distributed-acoustic-sensing-market

Further key findings from the report suggest:

The significant surge in the deployment of optical fiber sensors in oil and gas industries will create a massive potential for the distributed acoustic sensing market
Market players are focusing on providing optical fiber acoustic sensors for wellbores, which offers long-distance data transmission for subsea and downhole
Key market players are considering partnerships and acquisitions of startups providing innovative products to expand their outreach in the market
The key competitors in the market are OptaSense; Halliburton; Schlumberger Limited; Baker Hughes, a GE Company LLC; Future Fibre Technologies; Northrop Grumman Corporation; Fotech Solutions Ltd.; Omnisens; Silixa Ltd; and Ziebel; among others

Active Electronic Components Market Size Worth $495.2 Billion By 2025

The global active electronic components market size is estimated to reach USD 495.2 billion by 2025, registering a CAGR of 9.6% from 2019 to 2025, according to a new study by Grand View Research, Inc. Growing demand for active electronics components for manufacturing smart home appliances such as refrigerators, air conditioners, and washing machines among others, is estimated to boost the market growth. Moreover, the anticipated adoption of active electronic components in networking devices and telecom equipment requisite for developing 5G infrastructure is further expected to elevate the growth.

Wearables such as smartwatches, Virtual Reality (VR) headsets, and fitness bands among others are gaining popularity among consumers. Consumers are increasingly willing to spend a significant amount on health and entertainment, which in turn it has accelerated the demand for wearable devices among consumers worldwide. This is further anticipated to increase the adoption of active electronic components in the coming years. In addition, voluminous patient data coupled with investments made by the governments and private players worldwide for setting up state-of-the-art healthcare facilities has augmented the adoption of high-tech medical equipment and connected devices. Thus, with rising demand for these devices, the demand for active electronic components is expected to surge globally over the forecast period.

Demand for connected cars is fast transforming the automotive industry. This has increased the use of advanced electronics in automotive for multiple applications, such as parking, safety, telematics, and navigation among others. Thus, growing demand for advanced electronics in automotive is expected to drive demand for active electronic components over the forecast period. Also, the rising demand for advanced microcontrollers or modems in order to provide robust connectivity to autonomous cars and other critical applications is further expected to surge the adoption of active electronics components from 2019 to 2025.

With the rising trend of industry 4.0, the adoption of the Internet of Things (IoT) devices in the manufacturing sector is gradually increasing worldwide. Key manufacturers are opting for new technologies to augment their overall productivity and operational efficiency in order to ensure profitability. Therefore, the rising adoption of IoT technology for smart manufacturing applications, such as machine-to-machine communication is estimated to augment the adoption of active electronic components over the forecast period. Furthermore, the escalating trade war between U.S. and China is anticipated to restrict the overall market growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/active-electronic-components-market

Further key findings from the study suggest:

The active electronic components market in India is anticipated to register a CAGR of 12.8%, attributed to the rising investments by prominent smartphone manufacturers in view of establish their own manufacturing facilities in the country
The Integrated Circuits (ICs) segment held a market size exceeding USD 80 billion in 2018, attributed to the robust increase in the demand for ICs integrated with state-of-the-art devices such smartphone, laptops, vehicle automation systems, and network devices among others
Significantly growing demand for active electronic components across next-generation devices such as 5G-enabled smartphones, gaming consoles, and other consumer electronics is estimated to fuel the consumer devices segment growth from 2019 to 2025
Several key market players are focusing on mergers and acquisitions in order to strengthen their market presence and expand their product portfolios
Prominent market players include Infineon Technologies AG; NXP Semiconductors NV; Texas Instruments Incorporated; Toshiba Corporation; STMicroelectronics; Semiconductor Components Industries, LLC; Intel Corporation; Maxim Integrated; Renesas Electronics Corporation; Broadcom Inc.; Qualcomm Inc.; Analog Devices, Inc.; Advanced Micro Devices; Microchip Technology Inc.; and Monolithic Power Systems Inc.

Sound Recognition Market Worth $4.42 Billion By 2025

The global sound recognition market size is expected to reach USD 4.42 billion by 2025, exhibiting a CAGR of 75.8% over the forecast period, according to a new report published by Grand View Research, Inc. Sound recognition runs on inexpensive microcontrollers that result in a low bill of materials, thereby providing an economical solution. It is highly flexible since it can detect various sounds and allows users to add their sound event classifiers, thereby providing easy customization of sound event. Thus, high flexibility and low cost are expected to propel the market growth.

Sound recognition technology is used for various purposes, such as music recognition and speech recognition among others. Increasing adoption across applications such as for monitoring and surveillance system for automatic alarm detection and rising use in smart safety solutions are the factors expected to drive the market growth. Other factors, such as increasing adoption of advanced technologies including Artificial Intelligence (AI), machine learning, Internet of Things (IoT), and others, are anticipated to further drive the adoption of sound recognition in the forthcoming years.

The artificial intelligence-based sound recognition technology is expected to register a high CAGR over the forecast period. This is due to increasing involvement of market vendors in developing sound recognizing products integrated with intelligent technology to provide customers with ease and flexibility. In the application segment, the automotive section is expected to gain moderate traction. This is due to factors such as integration of sound recognition technology in autonomous cars to recognize sounds inside and outside the car and improve safety.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sound-recognition-market

Further key findings from the report suggest:

Increasing adoption of sound recognition technology for emergency vehicle detection condition monitoring and wear detection, amongst others are factors driving growth of the automotive segment
Benefits such as high efficiency due to edge processing and high control and awareness with the help of real-time analytics are driving the sound recognition market growth
Vendors in the Europe market are gaining a competitive edge in the market by receiving substantial investments from companies such as Cambridge Innovation Capital plc and IQ Capital for enhancing their exiting sound recognition technology
Wavio, OtoSense, abilisense, Reality AI, and Audio Analytic Ltd. are some of the key plyayers operating in the market

U.S. Sterilization Services Market Size Worth 2.72 Billion By 2025

The U.S. sterilization services market size is expected to reach USD 2.72 billion by 2025, according to a new report by Grand View Research, Inc., registering a 5.1% CAGR during the forecast period. Supportive government investments in the healthcare industry, increasing R&D activities, and rising volume of drug launches are key factors impacting market growth.

The U.S. government has been keen on curbing healthcare costs and this is anticipated to encourage the FDA to speed up approval procedures for generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods, compelling innovative market participants to spend more on such solutions, thereby propelling the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, or for a new indication. These launches require thorough sterility testing and this is anticipated to drive market growth.

By end use, the market is divided into hospitals, pharmaceuticals, medical device companies, clinical laboratories/research centers, and others, which includes food and beverage companies. Hospitals dominated the overall sterilization services market in 2016 and the segment is expected to retain its top position throughout the forecast period. Increasing incidence of hospital-acquired infections, growing number of surgical procedures, and constantly rising patient pool are prime factors driving this segment.

Currently, the U.S. sterilization services industry is consolidated in nature with only a few top companies capturing the major share. Some of the leading players are STERIS Corporation; Getinge Group; and Advanced Sterilization Products Services, Inc. Other prominent companies include 3M, Belimed, Cantel Medical, MATACHANA GROUP, and Sterigenics International LLC. In September 2016, Cantel announced the acquisition of Vantage Endoscopy’s endoscopy assets. This expansion of direct sales and acquisition of assets of its Canadian distributor is expected to strengthen the company’s position in the infection prevention market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/us-sterilization-services-market

Further key findings from the study suggest:

The U.S. sterilization services market was valued at USD 1.83 billion in 2017 and is expected to grow lucratively over the forecast period
In terms of revenue, the offsite delivery mode segment is anticipated to exhibit a strong growth rate through 2025
The contract services market was valued at USD 1.27 billion in 2017 and is anticipated to register the fastest CAGR over the forecast period.

Myeloproliferative Disorders Drugs Market Worth $9.26 Billion By 2023

The global myeloproliferative disorder drugs market size is expected to be valued at USD 9.26 billion by 2023, as per a new report by Grand View Research, Inc., expanding at a CAGR of 3.4% during the forecast period. Availability of novel drugs, the presence of a strong pipeline, rising incidence of myeloproliferative disorders due to changing lifestyles, growing geriatric population, and increasing public awareness are some of the primary growth stimulants for the market. Therapeutic development in the second-line setting for Jakafi-intolerant patients is estimated to work in favor of the Ph- MPNs market.

Chronic myeloproliferative disorders are rare hematological malignances that involve the abnormal accumulation of mature myeloid cells (red blood cells, granulocytes, and platelets) and their precursors (myelocytes, metamyelocytes, nucleated red blood cells, and megakaryocytes) in the peripheral blood and bone marrow. This class of disorder includes four main myeloproliferative diseases, which are further categorized by the presence of the Philadelphia chromosome.

There is a higher incidence of myeloproliferative disorders in North America and Western Europe as compared to East-Asian countries. Most patients are diagnosed with MPNs after 60 years of age, however, the diseases can occur in any age group. The U.S. will be the most prominent market for myeloproliferative disorders drugs owing to the presence of a large target population.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/myeloproliferative-disorders-drugs-market

Further key findings from the study suggest:

The U.S. accounted for more than 45.0% of the market in 2017. Spiraling adoption of novel therapeutics and multiple product launches during the forecast period are anticipated to support the prominence of the market in the global arena over the coming years
Strong unmet needs are likely to shape the future of the market and encourage the development of breakthrough first-in-class therapies. Opportunities remain in the Ph- MPNs setting where there exists an unmet need for a safer drug than Jakafi with higher cure rates and lesser allergic effects
Some of the key market participants are Novartis, Bristol-Myers Squibb, Pfizer, Takeda, Incyte, and Teva. Primary go-to strategies of prominent players include collaborations for the development and regional expansion in emerging markets.

Huntington’s Disease Treatment Market Size Worth $1.5 Billion by 2023

The global huntington’s disease treatment market size is expected to be valued at USD 1.5 billion by 2023, as per a new report by Grand View Research, Inc., registering a CAGR of 38.2% during the forecast period. The market is largely driven by factors such as rapid uptake of disease-modifying therapies, increased adoption of novel therapeutics, and increase in R&D activities.

Huntington’s disease is an inherited neurodegenerative disorder characterized by a combination of motor, cognitive, and psychiatric symptoms. Currently, only two symptom-alleviating therapies are specifically approved for this disorder: Xenazine and Austedo. Off-label medications are used extensively due to lack of approved alternatives.

The pipeline for Huntington’s disease is expected to witness rapid developments in the coming years as disease-modifying drugs transform the market landscape. Improved disease understanding has led to significant progress in the development of therapeutic approaches aimed at modifying specific changes linked to the causative mutation. The potential role of RNA antisense technology and stem cell therapy are under active clinical investigation. Wave Life Sciences and Ionis Pharma’s antisense oligonucleotides aim to target underlying disease cause and are expected to contribute significantly to market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/huntingtons-disease-treatment-market

Further key findings from the report suggest:

Teva is projected to become the market leader, capturing more than 45% of the market in 2023, driven by Austedo’s rapid uptake and improved efficacy profile compared to its competitors. Teva’s Huntexil is expected to be the only new symptom-alleviating drug to be launched during the forecast period
Raptor’s RP103 is expected to face head-to-head competition from Prana Biotech’s Phase II drug PBT2 to be the first disease modifying therapy to be launched in the market
Currently, 23 products are under clinical investigation for Huntington’s disease, out of which, one is in Phase II/III each, thirteen in Phase II trials, two in Phase Ib/IIa, six in pre-clinical trials, and one in discovery phase
EU5 will remain the second largest market with more than 15% share in 2023, driven by rising disease prevalence, novel drug launches, and increase in R&D activities
Companies are now focusing on development of treatments that can be injected directly in the brain to directly inhibit the formation of mutant HTT protein, instead of targeting the mutant protein
Drugs with novel targets in early-phase development include Stealth Biotherapeutics’ SBT-20 (mitochondria-targeted cytoprotective peptide), Cellavita + Azidus Brazil’s Cellavita HD (stem cell therapy), Sangamo/ Shire’s mHTT ZFP (zinc finger protein), and UniQure’s AMT-130 (gene therapy).

Oligonucleotide Synthesis Market Size Worth $3.9 Billion By 2025

The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth.

The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products.

A substantial number of oligos are being investigated for their usage in targeting various infectious diseases. For instance, dsDNA thioaptamers are reported to target the ribonuclease H (RNase H) domain of HIV-RT and are demonstrated to inhibit HIV-RT when used in vitro.

In addition, demand for cancer-related thioapatmers that can detect presence as well as target tumor growth factors, such as TGF-β, is on a continuous rise. This, in turn, has led to increase in investments for exploring the significance of custom oligonucleotide synthesis in cancer research.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/oligonucleotide-synthesis-market

Further key findings from the report suggest:

Growing usage of ready as well as custom oligos in genomic research is expected to drive the market
Column-based oligos have a higher per nucleotide base price compared to array-based oligos. As a result, column-based oligos accounted for the largest revenue share by product type in 2017
North America dominated the global market in 2017 as a result of large investments in genetic research and effective regulatory policies that encourage gene-based research activities in the region
Asian countries are expected to emerge as a key source of lucrative revenue generation during the forecast period. This is primarily due to growing awareness as well as popularity of genetic medicine among the population
The market is highly fragmented, with the presence of several major and emerging players offering DNAs, RNAs, and other oligos. Market competition is anticipated to increase with growing number of new entrants offering customized services
Some of the key companies in the market are BioAutomation; Integrated DNA Technologies, Inc.; LGC Biosearch Technologies; Agilent Technologies; GE Healthcare Dharmacon Inc.; and Gene Scripts.